FDA 483 - New Vision Pharmaceuticals LLC - March 23, 2023
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of New Vision Pharmaceuticals LLC in Tamarac, FL, a sterile drug manufacturer, revealed significant deficiencies across multiple areas. Observations included inadequate procedures for preventing microbiological contamination, insufficient validation of aseptic processes, and a lack of established production and process controls for sterile drug products. Additionally, the firm failed to properly follow quality control unit responsibilities and maintain adequate equipment cleaning procedures.
ID · a9e9e9b5-acdf-4f6b-b821-d0e0af0d0edc